FDA.reportPublic FDA data

HYPROMELLOSE 2208 (3 MPA.S)

Substance profile for UNII 9H4L916OBU, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
9H4L916OBU
Preferred term
HYPROMELLOSE 2208 (3 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300446
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300446mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300446
FDA Substance Registration System9H4L916OBUprecision.fda.gov/uniisearch/srs/unii/9H4L916OBU

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
These highlights do not include all the information needed to use warfarin sodium tablets USP safely and effectively. See full prescribing information for warfarin sodium. Initial U.S. Approval: 19541000
Escitalopram Tablets, USP These highlights do not include all the information needed to use Escitalopram safely and effectively. See full prescribing information for Escitalopram. Escitalopram (Escitalopram) TABLET for ORAL use. Initial U.S. Approval: 20024
Escitalopram Tablets, USP These highlights do not include all the information needed to use Escitalopram safely and effectively. See full prescribing information for Escitalopram. Escitalopram (Escitalopram) TABLET for ORAL use. Initial U.S. Approval: 20021
These highlights do not include all the information needed to use warfarin sodium tablets USP safely and effectively. See full prescribing information for warfarin sodium. Initial U.S. Approval: 19542
20/20 Topical Anesthetic Strip2
These highlights do not include all the information needed to use warfarin sodium tablets USP safely and effectively. See full prescribing information for warfarin sodium. Initial U.S. Approval: 19541
These highlights do not include all the information needed to use fexofenadine hydrochloride tablets USP safely and effectively. See full prescribing information for fexofenadine hydrochloride tablets USP. Fexofenadine hydrochloride tablets USP for oral use. Initial U.S. Approval: 19961
METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS USP, 500 mg and 750 mg 7267 7212 Rx only1
WARFARIN SODIUM TABLET [PD-RX PHARMACEUTICALS, INC.]10
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]9
WARFARIN SODIUM TABLET [BARR LABORATORIES INC.]9
GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE GALANTAMINE TABLET, FILM COATED [BARR LABORATORIES INC.]7
SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.]6
DEXMETHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]5
KELNOR 1/35 (ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.]5
SINEMET CR (CARBIDOPA AND LEVODOPA) TABLET, EXTENDED RELEASE [MERCK SHARP & DOHME CORP.]5
TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.]5
LESSINA (LEVONORGESTREL AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.]4
PORTIA (LEVONORGESTREL AND ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.]4
METHYLPHENIDATE HYDROCHLORIDE (LA) (METHYLPHENIDATE HYDROCHLORIDE) CAPSULE, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]3
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [WALGREENS COMPANY]3
ESCITALOPRAM TABLET [LEGACY PHARMACEUTICAL PACKAGING]2
NABUMETONE TABLET, FILM COATED [LUPIN PHARMACEUTICALS, INC.]2
OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [THE KROGER CO.]2
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [KAISER PERMANENTE]2
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [MEIJER DISTRIBUTION INC]2
QUARTETTE (LEVONORGESTREL/ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL) KIT [TEVA WOMEN'S HEALTH, INC.]2
ESCITALOPRAM TABLET [REMEDYREPACK INC. ]1
METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [REMEDYREPACK INC. ]1
OFLOXACIN TABLET, FILM COATED [LARKEN LABORATORIES, INC.]1
OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [TARGET CORPORATION]1
OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [THE KROGER CO.]1
OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM 20.6MG CAPSULES) CAPSULE, DELAYED RELEASE [WAL-MART STORES INC]1
OMEPRAZOLE MAGNESIUM (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [FREDS]1
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [CHAIN DRUG CONSORTIUM, LLC ]1
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION]1
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [GERICARE PHARMACEUTICALS]1
OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [HEB]1
PRAMLYTE (ESCITALOPRAM OXYLATE, CHOLECALCIFEROL, PYRIDOXAL PHOSPHATE ANHYDROUS, LEVOMEFOLATE MAGNESIUM, AND METHYLCOBALAMIN) KIT [ALLEGIS PHARMACEUTICALS, LLC]1
PRAMLYTE (ESCITALOPRAM, LEUCOVORIN, FOLIC ACID, LEVOMEFOLATE MAGNESIUM, FERROUS CYSTEINE GLYCINATE, 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM, PHOSPHATIDYL SERINE, PYRIDOXAL 5-PHOSPHATE, FLAVIN ADENINE DINUCLEOTIDE, NADH, COBAMAMIDE, COCARBOXYLASE (THIAMINE PYROPHOSPHATE), MAGNESIUM ASCORBATE, ZINC ASCORBATE, MAGNESIUM L-THREONATE AND BETAINE) KIT [ALLEGIS PHARMACEUTICALS, LLC]1
TRI-SPRINTEC (NORGESTIMATE AND ETHINYL ESTRADIOL) KIT [PROFICIENT RX LP]1
WARFARIN SODIUM TABLET [REMEDYREPACK INC. ]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII 9H4L916OBU page 1 of 1 ยท 7 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653CAPSULEORAL19 mg
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653CAPSULE, DELAYED RELEASEORAL40 mg
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653CAPSULE, EXTENDED RELEASEORAL24 mg
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653SUSPENSIONORAL15 mg
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653TABLETORAL428 mg
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653TABLET, EXTENDED RELEASEORAL38 mg
HYPROMELLOSE 2208 (3 MPA.S)9H4L916OBU9004653TABLET, FILM COATED, EXTENDED RELEASEORAL470 mg